Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Spectral AI, Inc. stock logo
MDAI
Spectral AI
$2.51
-6.0%
$2.06
$0.82
$3.25
$63.55M0.9902,879 shs789,791 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$2.39
-0.8%
$2.39
$1.99
$3.80
$73.22M0.5770,144 shs58,761 shs
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
$0.80
+2.6%
$0.76
$0.29
$0.98
$19.54M0.8420,458 shs27,186 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.34
-2.3%
$4.71
$4.01
$9.33
$71.37M1.29188,400 shs73,310 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Spectral AI, Inc. stock logo
MDAI
Spectral AI
0.00%-12.24%+19.52%+102.42%+31.41%
InspireMD, Inc. stock logo
NSPR
InspireMD
0.00%+1.27%-1.24%-7.72%-1.65%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
0.00%+1.27%+14.29%+43.96%+45.72%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%+4.33%-8.44%-5.45%-25.17%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Spectral AI, Inc. stock logo
MDAI
Spectral AI
3.3698 of 5 stars
3.75.00.00.01.83.30.0
InspireMD, Inc. stock logo
NSPR
InspireMD
2.4843 of 5 stars
3.53.00.00.00.62.50.6
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
N/AN/AN/AN/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.0408 of 5 stars
3.50.00.00.01.90.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Spectral AI, Inc. stock logo
MDAI
Spectral AI
3.33
Buy$4.7589.24% Upside
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.5088.28% Upside
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
0.00
N/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.00
Buy$11.67168.82% Upside

Current Analyst Ratings Breakdown

Latest PETV, MDAI, NSPR, and SRTS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
5/12/2025
InspireMD, Inc. stock logo
NSPR
InspireMD
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$4.50 ➝ $4.00
(Data available from 7/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Spectral AI, Inc. stock logo
MDAI
Spectral AI
$29.58M2.15N/AN/A($0.32) per share-7.84
InspireMD, Inc. stock logo
NSPR
InspireMD
$7.03M10.42N/AN/A$1.83 per share1.31
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
$1.05M18.68N/AN/A($0.03) per share-26.67
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.71$0.43 per share10.05$3.41 per share1.27
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Spectral AI, Inc. stock logo
MDAI
Spectral AI
-$15.31M-$0.54N/AN/AN/A-30.75%N/A-11.37%N/A
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.79N/AN/AN/A-413.96%-69.42%-57.68%N/A
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
-$10.95M-$0.42N/AN/A-902.82%-4,813.07%-281.78%8/12/2025 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1043.4018.87N/A4.56%3.34%3.00%8/6/2025 (Estimated)

Latest PETV, MDAI, NSPR, and SRTS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.01N/AN/AN/A$9.30 millionN/A
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Spectral AI, Inc. stock logo
MDAI
Spectral AI
N/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Spectral AI, Inc. stock logo
MDAI
Spectral AI
N/A
1.41
1.37
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
0.02
0.42
0.47
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.06
5.74

Institutional Ownership

CompanyInstitutional Ownership
Spectral AI, Inc. stock logo
MDAI
Spectral AI
67.08%
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
24.55%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Spectral AI, Inc. stock logo
MDAI
Spectral AI
30.70%
InspireMD, Inc. stock logo
NSPR
InspireMD
34.06%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
10.84%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Spectral AI, Inc. stock logo
MDAI
Spectral AI
8325.32 million17.55 millionNot Optionable
InspireMD, Inc. stock logo
NSPR
InspireMD
5030.64 million18.33 millionOptionable
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
2024.42 million19.06 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Spectral AI stock logo

Spectral AI NASDAQ:MDAI

$2.51 -0.16 (-5.99%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$2.51 +0.00 (+0.04%)
As of 07/18/2025 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.

InspireMD stock logo

InspireMD NYSE:NSPR

$2.39 -0.02 (-0.83%)
Closing price 07/18/2025 03:48 PM Eastern
Extended Trading
$2.34 -0.06 (-2.30%)
As of 07/18/2025 06:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

PetVivo stock logo

PetVivo NASDAQ:PETV

$0.80 +0.02 (+2.56%)
As of 07/18/2025 03:38 PM Eastern

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.34 -0.10 (-2.25%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$4.33 -0.01 (-0.23%)
As of 07/18/2025 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.